STI & LTI have become a joke

[anonymous]

If you are looking for a job and not a sales rep, you may qualify for STI and LTI. I advise you, run away! What used to be a decent incentive is down down to 30% and 10% of their promised value respectively. The system is a joke now and in no way competitive nor attractive. I imagine soon they won't have to layoff people because they will voluntarily will leave due to lack of proper compensation.

 

[anonymous]

If you are looking for a job and not a sales rep, you may qualify for STI and LTI. I advise you, run away! What used to be a decent incentive is down down to 30% and 10% of their promised value respectively. The system is a joke now and in no way competitive nor attractive. I imagine soon they won't have to layoff people because they will voluntarily will leave due to lack of proper compensation.

It’s been like this for the last 2 years with no positive outlook in sight. This place used to be so fulfilling and worth my time now it’s not. I’ve been looking and have much more promising places to land. Thankfully. If you’re not looking you should. Bayer is a sinking ship

 

[anonymous]

It’s been like this for the last 2 years with no positive outlook in sight. This place used to be so fulfilling and worth my time now it’s not. I’ve been looking and have much more promising places to land. Thankfully. If you’re not looking you should. Bayer is a sinking ship

This place is a colossal waste of anyone’s time. If you are looking. Run if you are employees here this place is a dead end- no promotions, barely any higher positions to be promoted to, meriit sucks. Bonus is basically non existing. The wheels have fallen off this bus with no recovery in sight. .

 

[anonymous]

This place is a colossal waste of anyone’s time. If you are looking. Run if you are employees here this place is a dead end- no promotions, barely any higher positions to be promoted to, meriit sucks. Bonus is basically non existing. The wheels have fallen off this bus with no recovery in sight. .

That’s really unfortunate there are lots of Pharma companies doing really well right now and paying out. Don’t feel stuc. collect your shit and leave. Why bust your ass for your job where you literally take over more jobs and responsibilities from those that leave with no additional benefit for a company that does not pay cannot promote and has no loyalty to you. There are many places that actually care. Bayer used to but they haven’t in a long while. Ask Genentech how they’re doing years after BA ruined them- there is no winning here or bouncing back. Don’t be a fool. If you’re not being cut now you will.

 

[anonymous]

Bayer perfectly exemplifies "The Peter Principle," as they often promote individuals internally who lack the necessary skills for their new roles. For example, in Market Access, we have a leader with no relevant experience, and in Account Management, there's a leader who treats customers as adversaries. This approach results in dysfunctional relationships with Pharmacy Benefit Managers (PBMs) and various payers. In Sales, a leader with a poor track record of managing several brands continues to be given even more responsibilities. Meanwhile, in Marketing, a leader's micromanagement style and reluctance to challenge the status quo lead to uninspired and ineffective resources.

The STI and LTI programs are likely to fail due to these issues, which hinder the organization's ability to forecast, launch products effectively, and motivate the sales force. This is evident in the declining stock price and waning investor confidence. There are multiple discussions on this site and in recent reviews that clearly illustrate these problems are not just complaints from disgruntled sales representatives, but rather a reflection of a lost company culture.

 

[anonymous]

Bayer perfectly exemplifies "The Peter Principle," as they often promote individuals internally who lack the necessary skills for their new roles. For example, in Market Access, we have a leader with no relevant experience, and in Account Management, there's a leader who treats customers as adversaries. This approach results in dysfunctional relationships with Pharmacy Benefit Managers (PBMs) and various payers. In Sales, a leader with a poor track record of managing several brands continues to be given even more responsibilities. Meanwhile, in Marketing, a leader's micromanagement style and reluctance to challenge the status quo lead to uninspired and ineffective resources.

The STI and LTI programs are likely to fail due to these issues, which hinder the organization's ability to forecast, launch products effectively, and motivate the sales force. This is evident in the declining stock price and waning investor confidence. There are multiple discussions on this site and in recent reviews that clearly illustrate these problems are not just complaints from disgruntled sales representatives, but rather a reflection of a lost company culture.
I could not agree with this post more. "The Peter Principle" has gone rampant at Bayer. Not just within marketing and market access but across both Product and Pipeline and Customer Facing Teams and within CVR and Oncology. The amount of talent that has been pushed out and the amount of 'individuals who lack the necessary skills for their new roles" retained is it at an all time high. There are WAY TO MANY people who were saved based on their leadership 'band' from their former role that lack the necessary skills to actually do the job effectively.
Examples: (1) We pushed out someone in Incentive Compensation who was outstanding because they did not carry a senior director title only to post an opening outside of the organization the following Monday. How is that right to dispose of a good employee who did nothing wrong because they did not have as much experience as what they THINK THEY need? How did that work out for them- isn't it still posted? You cannot even pay people to want to come here these days. (2) Why did we keep marketers in roles that are not good employees? We saw disaster after disaster from some of the marketers some which could not even speak English well enough or manage high pressured asks time after time. (3) How can we allow a person (Marketer and former FFE) who have been career HQ people and never stepped foot in the field. They know nothing about sales be allowed to take a field sales positions with sales managers having no say in the decision. As an industry, Oncology and Rare Disease are seen as the most elite and highest level paid reps within in the industry- it takes YEARS and many awards, experiences and successes to be fortunate enough to be hired into an Oncology position. That said, it is the biggest insult to many of those reps who have devoted their careers and worked hard to finally land the prestigious opportunity to sell within the Oncology landscape. To have marketers who believe that they can politicize and back door their people into these roles with no experience over people who are more than qualified is disgusting only to give someone some experience. We have WHC and Kerendia opening to provide the level of experience that they need to understand. In the end, it does your customers a disservice and it belittles those who deserved those seats at the table.

The way that Bayer is conducting its business and making their decisions is only going to bite them in the ass. I hope that the talented leave and land themselves in roles that are competitive for companies who appreciate them. Those who remain here, for the select few who are good people, those left that continue to ride this training thinking it's going to a better destination. Best of luck but you reap what you sow.

 

[anonymous]

Bayer perfectly exemplifies "The Peter Principle," as they often promote individuals internally who lack the necessary skills for their new roles. For example, in Market Access, we have a leader with no relevant experience, and in Account Management, there's a leader who treats customers as adversaries. This approach results in dysfunctional relationships with Pharmacy Benefit Managers (PBMs) and various payers. In Sales, a leader with a poor track record of managing several brands continues to be given even more responsibilities. Meanwhile, in Marketing, a leader's micromanagement style and reluctance to challenge the status quo lead to uninspired and ineffective resources.

The STI and LTI programs are likely to fail due to these issues, which hinder the organization's ability to forecast, launch products effectively, and motivate the sales force. This is evident in the declining stock price and waning investor confidence. There are multiple discussions on this site and in recent reviews that clearly illustrate these problems are not just complaints from disgruntled sales representatives, but rather a reflection of a lost company culture.

I co
I could not agree with this post more. "The Peter Principle" has gone rampant at Bayer. Not just within marketing and market access but across both Product and Pipeline and Customer Facing Teams and within CVR and Oncology. The amount of talent that has been pushed out and the amount of 'individuals who lack the necessary skills for their new roles" retained is it at an all time high. There are WAY TO MANY people who were saved based on their leadership 'band' from their former role that lack the necessary skills to actually do the job effectively.
Examples: (1) We pushed out someone in Incentive Compensation who was outstanding because they did not carry a senior director title only to post an opening outside of the organization the following Monday. How is that right to dispose of a good employee who did nothing wrong because they did not have as much experience as what they THINK THEY need? How did that work out for them- isn't it still posted? You cannot even pay people to want to come here these days. (2) Why did we keep marketers in roles that are not good employees? We saw disaster after disaster from some of the marketers some which could not even speak English well enough or manage high pressured asks time after time. (3) How can we allow a person (Marketer and former FFE) who have been career HQ people and never stepped foot in the field. They know nothing about sales be allowed to take a field sales positions with sales managers having no say in the decision. As an industry, Oncology and Rare Disease are seen as the most elite and highest level paid reps within in the industry- it takes YEARS and many awards, experiences and successes to be fortunate enough to be hired into an Oncology position. That said, it is the biggest insult to many of those reps who have devoted their careers and worked hard to finally land the prestigious opportunity to sell within the Oncology landscape. To have marketers who believe that they can politicize and back door their people into these roles with no experience over people who are more than qualified is disgusting only to give someone some experience. We have WHC and Kerendia opening to provide the level of experience that they need to understand. In the end, it does your customers a disservice and it belittles those who deserved those seats at the table.
The way that Bayer is conducting its business and making their decisions is only going to bite them in the ass. I hope that the talented leave and land themselves in roles that are competitive for companies who appreciate them. Those who remain here, for the select few who are good people, those left that continue to ride this training thinking it's going to a better destination. Best of luck but you reap what you sow.

The way that Bayer is conducting its business and making their decisions is only going to bite them in the ass. I hope that the talented leave and land themselves in roles that are competitive for companies who appreciate them. Those who remain here, for the select few who are good people, those left that continue to ride this training thinking it's going to a better destination. Best of luck but you reap what you sow.

 

[anonymous]

The way that Bayer is conducting its business and making their decisions is only going to bite them in the ass. I hope that the talented leave and land themselves in roles that are competitive for companies who appreciate them. Those who remain here, for the select few who are good people, those left that continue to ride this training thinking it's going to a better destination. Best of luck but you reap what you sow.

Well those that made out better in the deal will continues to be fooled because they are fools themselves.

 

[anonymous]

Well those that made out better in the deal will continues to be fooled because they are fools themselves.

The only people who remain at Bayer are complacent individuals who are too lazy to seek better opportunities or content with just a paycheck. Meanwhile, VPs receive bonuses of over 40% on their already high salaries, rewarded for minimal performance. There is not a worst run pharmaceutical company!

 

[anonymous]

The only people who remain at Bayer are complacent individuals who are too lazy to seek better opportunities or content with just a paycheck. Meanwhile, VPs receive bonuses of over 40% on their already high salaries, rewarded for minimal performance. There is not a worst run pharmaceutical company!

Now that sounds like some back ended bullshit and not suprising good luck to their 40% next year when we are bankrupt or they have to sell their shit drugs themselves. Marketing has done such a great job already trying to sell- telling.